303:
Kendall founded Vaxxas in 2011 to advance his
Nanopatch technology for global impact, securing more than $ 40 million of investment, in the series A ($ 15m) and B (in excess of $ 25m) rounds. The Nanopatch technology has been licensed to Merck & Co. He served as the Vaxxas Chief Technology
299:
As
Associate Director of the Oxford University PowderJect Research Centre (2000-2006), Kendall advanced biolistics technology, commercialised with PowderJect, purchased by Chiron (later Novartis) in 2003; and then with PowderMed, purchased by Pfizer in 2006.
100:, where he led a team at the Australian Institute for Bioengineering and Nanotechnology. He was Founder, CTO and a Director of Vaxxas. Prior to this, in the UK, he was a University Research Lecturer at the
716:
600:
544:
1321:
Queensl, The
University of; Lucia, Australia Brisbane St; Gatton, QLD 4072 +61 7 3365 1111 Other Campuses: UQ; Maps, UQ Herston; Queensl, Directions © 2020 The University of.
1281:
Queensl, The
University of; Lucia, Australia Brisbane St; Gatton, QLD 4072 +61 7 3365 1111 Other Campuses: UQ; Maps, UQ Herston; Queensl, Directions © 2020 The University of.
146:
685:
1206:
800:
932:
1231:
1009:
933:"Nanopatch Delivery of DNA-Based Malaria Vaccines to Skin: Precisely Targeting the Skin Immune System for Radically Improved Vaccines | Grand Challenges"
118:
Kendall has filed more than 160 patents (including territories), published in excess of 300 papers, licensed his technologies seven times (including to
855:
476:
1347:
1307:
741:
608:
552:
133:
Kendall's contributions to innovation in global healthcare has been recognised with more than forty awards. These include recent elections as:
767:
349:
1282:
1417:
130:. The biotech enterprises he has founded or made significant contribution to have generated in the region of $ 2 billion Aus in value.
1322:
211:(1998-2006) Kendall developed a biolistic technique for the delivery of vaccines directly into the skin without the use of needles.
1412:
1156:
204:
Kendall has over 160 patent applications of which, 128 have been granted to date. He has authored more than 300 refereed papers.
1177:
808:
1084:
229:
127:
257:
Elected Fellow of the Royal
Society for the encouragement of Arts, Manufacture and Commerce (now the RSA), UK (2017).
1402:
275:
Rolex
Laureate Award for Enterprise (2012) for his "pioneering efforts to expand knowledge and improve human life".
177:
Kendall was born on 16 April 1972. He received his
Bachelors of Engineering (Hons I, 1993) and PhD (1998) from the
108:. Whilst at Oxford, Kendall was Associate Director of the PowderJect Research Centre for Gene and Drug Delivery.
881:
222:
193:
155:
Fellow of the Royal
Society for the encouragement of Arts, Manufacture and Commerce (now the RSA), UK; (2017).
90:
67:
1407:
477:"Mark Kendall elected as a Fellow of the Australian Academy of Technological Sciences and Engineering (ATSE)"
574:
376:
660:
260:
Elected to the World
Economic Forum Global Future Council on Entrepreneurship and Innovation (2016-2018).
161:
Kendall's work regularly features in international media, including on the
National Geographic Channel.
184:
In 1998, Kendall moved to the UK to take up a position in the Department of Engineering Science at the
89:
He is Founder and CEO of WearOptimo Pty Ltd and the Vice-Chancellor's Entrepreneurial Professor at the
111:
Kendall serves at the co-chair of the $ 150 million Australian Stem Cell Therapies Mission and on the
1257:"Nanotechnology Now - Press Release: Needle-free vaccine technology a step closer to clinical trials"
656:
233:
123:
1131:
1059:
215:
189:
178:
105:
97:
1110:
398:
957:
1397:
530:
423:
251:
Elected to the World Economic Forum Global Future Council on Biotechnology (2019 to present).
225:(2018 to present), Kendall has invented the Microwearable™ sensor for personalised medicine.
228:
During his career, Kendall has collaborated with major global health partners including the
1392:
503:
208:
185:
112:
101:
1034:
8:
856:"WearOptimo and ANU: towards a healthcare future within the fourth industrial revolution"
86:(born 1972) is an Australian biomedical engineer, inventor, scientist and entrepreneur.
448:
1256:
1341:
1301:
775:
768:"Vaccine patch offers pain-free way to stop disease in Papua New Guinea | John Vidal"
518:
49:
907:
690:
254:
Elected Fellow of the Australian Academy of Technology and Engineering ATSE (2017).
982:
831:"About | WearOptimo | Established by Professor Mark Kendall | Brisbane Australia"
218:(2006-2018) Kendall invented the Nanopatch for needle-free delivery of vaccines.
237:
119:
1386:
779:
631:
167:
1202:
263:
742:"UQ technology with the power to revolutionise global vaccine delivery"
304:
Officer, Director, and Chair of the Vaxxas Advisory Board (2011-2015).
284:
2010 Merck Translational Research Excellence Commercialisation Award.
164:
Kendall's TedGlobal talk has been viewed more than a million times.
96:
Kendall was formerly the Professor of Biomedical Engineering at the
1283:"New vaccine delivery company starts with AUD15 million investment"
1232:"ARC Future Fellow pioneers needle-free immunisation for the world"
1010:"ARC Future Fellow pioneers needle-free immunisation for the world"
830:
424:"After 160 years, it's time to move on from the needle and syringe"
242:
He is an Australian Government Academy of Science COVID-19 Expert.
269:
Dr John Dixon Hughes Medal for Medical Research Innovation (2016).
717:"Nanopatch—Revolutionising treatment of disease across the globe"
1361:
324:
287:
2005 Best Medical Innovation Award (Popular Science magazine).
1085:"Professor Mark Kendall wins the 2016 CSL Young Florey Medal"
502:
Australian Institute of, Policy and Science (27 April 2020).
1323:"Nanopatch vaccine technology company attracts $ 25 million"
307:
In 2018, Kendall founded WearOptimo where he serves as CEO.
158:
Kendall is a CSL Young Florey Medallist and Rolex Laureate.
147:
Australian Academy of Technological Sciences and Engineering
908:"Our Tech | WearOptimo | Microwearable devises | Australia"
1207:
Australian Institute for Bioengineering and Nanotechnology
686:"Professor Mark Kendall, 41, biomedical engineer/inventor"
1362:"Home | WearOptimo | Microwearable devices | Australia"
1035:"Expert - Mark Kendall | Australian Academy of Science"
575:"5 Times Rolex Helped to Make the World a Better Place"
501:
325:"Home | WearOptimo | Microwearable devices | Australia"
188:(1998-2006). He has subsequently held positions at the
350:"ANU welcomes funding for wearable medical technology"
245:
294:
1178:"4 things Australia needs to know about innovation"
679:
677:
1320:
1280:
649:
281:2011 Eureka Prize for Interdisciplinary Research.
199:
1384:
674:
139:World Economic Forum Technology Pioneer (2015).
272:World Economic Forum Technology Pioneer (2015).
601:"Fear of Needles? There's New Tech on the Way"
545:"Fear of Needles? There's New Tech on the Way"
1230:Council, Australian Research (19 July 2018).
1225:
1223:
1008:Council, Australian Research (19 July 2018).
801:""Nanopatch" Administers Vaccines Painlessly"
471:
469:
122:) and partnered globally, including with the
715:Council, Australian Research (5 June 2018).
278:2011 Australian Innovation Challenge winner.
1346:: CS1 maint: numeric names: authors list (
1306:: CS1 maint: numeric names: authors list (
1195:
1220:
882:"WearOptimo headquarters open in Brisbane"
710:
708:
466:
84:Mark A. F. Kendall (BE PhD FTSE FRSA FNAI)
1132:"Media Kit – 2016 CSL Young Florey Medal"
290:Younger Engineer of Great Britain (2004).
168:https://www.ted.com/speakers/mark_kendall
377:"Australian Stem Cell Therapies Mission"
115:Global Future Council on Biotechnology.
1229:
1007:
714:
705:
1385:
1111:"2016 – Professor Mark Kendall – AIPS"
1203:"Researchers: Professor Mark Kendall"
1157:"Previous Medal Winners - NFMRINFMRI"
765:
683:
805:National Geographic Society Newsroom
374:
629:
246:Selected Awards, Honours and Prizes
230:Bill & Melinda Gates Foundation
128:Bill & Melinda Gates Foundation
13:
1418:Alumni of the University of Oxford
958:"Nanopatch polio vaccine delivers"
807:. 26 November 2012. Archived from
607:. 14 November 2016. Archived from
551:. 14 November 2016. Archived from
295:Contributions to biotech companies
14:
1429:
684:Scott, Leisa (30 November 2013).
983:"Nanopatch creator Mark Kendall"
766:Vidal, John (26 December 2012).
1413:University of Queensland alumni
1354:
1314:
1274:
1249:
1170:
1149:
1124:
1103:
1077:
1052:
1027:
1001:
975:
950:
925:
900:
874:
848:
823:
793:
759:
734:
623:
593:
567:
396:
632:"Mark Kendall | Speaker | TED"
537:
495:
441:
416:
390:
368:
342:
317:
223:Australian National University
200:Contributions to Biotechnology
194:Australian National University
91:Australian National University
68:Australian National University
1:
1060:"The Future of Biotechnology"
310:
172:
375:Hunt, Greg (13 March 2019).
7:
661:Rolex Awards for Enterprise
10:
1434:
1136:www.scienceinpublic.com.au
428:www.scienceinpublic.com.au
266:Young Florey Medal (2016).
399:"Future of Biotechnology"
234:World Health Organization
124:World Health Organization
73:
63:
55:
45:
27:
20:
937:gcgh.grandchallenges.org
605:National Geographic News
549:National Geographic News
216:University of Queensland
190:University of Queensland
179:University of Queensland
106:Magdalen College, Oxford
98:University of Queensland
1403:Australian bioengineers
657:"Mark Kendall: Profile"
192:(2006-2018) and at the
987:Science Meets Business
221:At WearOptimo and the
579:Time and Tide Watches
1408:Biomedical engineers
1366:WearOptimo / to edit
1261:www.nanotech-now.com
1182:World Economic Forum
1064:World Economic Forum
912:WearOptimo / to edit
835:WearOptimo / to edit
504:"Young Florey Medal"
453:World Economic Forum
403:World Economic Forum
329:WearOptimo / to edit
209:University of Oxford
186:University of Oxford
113:World Economic Forum
102:University of Oxford
77:Biomedical invention
581:. 27 September 2016
59:Biomedical engineer
1091:. 11 November 2016
1039:www.science.org.au
529:has generic name (
104:and a lecturer at
483:. 17 October 2017
81:
80:
1425:
1377:
1376:
1374:
1372:
1358:
1352:
1351:
1345:
1337:
1335:
1333:
1318:
1312:
1311:
1305:
1297:
1295:
1293:
1278:
1272:
1271:
1269:
1267:
1253:
1247:
1246:
1244:
1242:
1227:
1218:
1217:
1215:
1213:
1199:
1193:
1192:
1190:
1188:
1174:
1168:
1167:
1165:
1163:
1153:
1147:
1146:
1144:
1142:
1128:
1122:
1121:
1119:
1117:
1107:
1101:
1100:
1098:
1096:
1081:
1075:
1074:
1072:
1070:
1056:
1050:
1049:
1047:
1045:
1031:
1025:
1024:
1022:
1020:
1005:
999:
998:
996:
994:
979:
973:
972:
970:
968:
954:
948:
947:
945:
943:
929:
923:
922:
920:
918:
904:
898:
897:
895:
893:
878:
872:
871:
869:
867:
862:. 2 October 2018
852:
846:
845:
843:
841:
827:
821:
820:
818:
816:
797:
791:
790:
788:
786:
763:
757:
756:
754:
752:
738:
732:
731:
729:
727:
712:
703:
702:
700:
698:
691:The Courier-Mail
681:
672:
671:
669:
667:
653:
647:
646:
644:
642:
627:
621:
620:
618:
616:
597:
591:
590:
588:
586:
571:
565:
564:
562:
560:
541:
535:
534:
528:
524:
522:
514:
512:
510:
499:
493:
492:
490:
488:
473:
464:
463:
461:
459:
445:
439:
438:
436:
434:
420:
414:
413:
411:
409:
394:
388:
387:
385:
383:
372:
366:
365:
363:
361:
346:
340:
339:
337:
335:
321:
196:(2018–Present).
145:Fellow of ATSE;
41:
37:
35:
18:
17:
1433:
1432:
1428:
1427:
1426:
1424:
1423:
1422:
1383:
1382:
1381:
1380:
1370:
1368:
1360:
1359:
1355:
1339:
1338:
1331:
1329:
1319:
1315:
1299:
1298:
1291:
1289:
1279:
1275:
1265:
1263:
1255:
1254:
1250:
1240:
1238:
1228:
1221:
1211:
1209:
1201:
1200:
1196:
1186:
1184:
1176:
1175:
1171:
1161:
1159:
1155:
1154:
1150:
1140:
1138:
1130:
1129:
1125:
1115:
1113:
1109:
1108:
1104:
1094:
1092:
1083:
1082:
1078:
1068:
1066:
1058:
1057:
1053:
1043:
1041:
1033:
1032:
1028:
1018:
1016:
1006:
1002:
992:
990:
989:. 24 April 2017
981:
980:
976:
966:
964:
956:
955:
951:
941:
939:
931:
930:
926:
916:
914:
906:
905:
901:
891:
889:
888:. 29 March 2019
880:
879:
875:
865:
863:
854:
853:
849:
839:
837:
829:
828:
824:
814:
812:
811:on 10 June 2020
799:
798:
794:
784:
782:
764:
760:
750:
748:
740:
739:
735:
725:
723:
713:
706:
696:
694:
682:
675:
665:
663:
655:
654:
650:
640:
638:
630:Kendall, Mark.
628:
624:
614:
612:
599:
598:
594:
584:
582:
573:
572:
568:
558:
556:
543:
542:
538:
526:
525:
516:
515:
508:
506:
500:
496:
486:
484:
475:
474:
467:
457:
455:
447:
446:
442:
432:
430:
422:
421:
417:
407:
405:
395:
391:
381:
379:
373:
369:
359:
357:
348:
347:
343:
333:
331:
323:
322:
318:
313:
297:
248:
238:Merck & Co.
202:
175:
120:Merck & Co.
39:
33:
31:
23:
12:
11:
5:
1431:
1421:
1420:
1415:
1410:
1405:
1400:
1395:
1379:
1378:
1353:
1313:
1273:
1248:
1236:www.arc.gov.au
1219:
1194:
1169:
1148:
1123:
1102:
1076:
1051:
1026:
1014:www.arc.gov.au
1000:
974:
949:
924:
899:
873:
847:
822:
792:
758:
733:
721:www.arc.gov.au
704:
673:
648:
622:
611:on 8 June 2020
592:
566:
555:on 8 June 2020
536:
494:
465:
440:
415:
389:
367:
341:
315:
314:
312:
309:
296:
293:
292:
291:
288:
285:
282:
279:
276:
273:
270:
267:
261:
258:
255:
252:
247:
244:
201:
198:
174:
171:
79:
78:
75:
74:Known for
71:
70:
65:
61:
60:
57:
53:
52:
47:
43:
42:
29:
25:
24:
21:
9:
6:
4:
3:
2:
1430:
1419:
1416:
1414:
1411:
1409:
1406:
1404:
1401:
1399:
1398:Living people
1396:
1394:
1391:
1390:
1388:
1367:
1363:
1357:
1349:
1343:
1328:
1324:
1317:
1309:
1303:
1288:
1284:
1277:
1262:
1258:
1252:
1237:
1233:
1226:
1224:
1208:
1204:
1198:
1183:
1179:
1173:
1158:
1152:
1137:
1133:
1127:
1112:
1106:
1090:
1086:
1080:
1065:
1061:
1055:
1040:
1036:
1030:
1015:
1011:
1004:
988:
984:
978:
963:
959:
953:
938:
934:
928:
913:
909:
903:
887:
883:
877:
861:
857:
851:
836:
832:
826:
810:
806:
802:
796:
781:
777:
773:
769:
762:
747:
743:
737:
722:
718:
711:
709:
693:
692:
687:
680:
678:
662:
658:
652:
637:
633:
626:
610:
606:
602:
596:
580:
576:
570:
554:
550:
546:
540:
532:
520:
505:
498:
482:
478:
472:
470:
454:
450:
444:
429:
425:
419:
404:
400:
393:
378:
371:
356:. 16 May 2018
355:
351:
345:
330:
326:
320:
316:
308:
305:
301:
289:
286:
283:
280:
277:
274:
271:
268:
265:
262:
259:
256:
253:
250:
249:
243:
240:
239:
235:
231:
226:
224:
219:
217:
212:
210:
205:
197:
195:
191:
187:
182:
180:
170:
169:
165:
162:
159:
156:
154:
150:
148:
144:
140:
138:
134:
131:
129:
125:
121:
116:
114:
109:
107:
103:
99:
94:
92:
87:
85:
76:
72:
69:
66:
62:
58:
54:
51:
48:
44:
40:(age 52)
38:16 April 1972
30:
26:
19:
16:
1369:. Retrieved
1365:
1356:
1330:. Retrieved
1326:
1316:
1290:. Retrieved
1286:
1276:
1264:. Retrieved
1260:
1251:
1239:. Retrieved
1235:
1210:. Retrieved
1197:
1185:. Retrieved
1181:
1172:
1160:. Retrieved
1151:
1139:. Retrieved
1135:
1126:
1114:. Retrieved
1105:
1093:. Retrieved
1088:
1079:
1067:. Retrieved
1063:
1054:
1042:. Retrieved
1038:
1029:
1017:. Retrieved
1013:
1003:
991:. Retrieved
986:
977:
965:. Retrieved
962:ScienceDaily
961:
952:
940:. Retrieved
936:
927:
915:. Retrieved
911:
902:
890:. Retrieved
885:
876:
864:. Retrieved
859:
850:
838:. Retrieved
834:
825:
813:. Retrieved
809:the original
804:
795:
783:. Retrieved
772:The Guardian
771:
761:
749:. Retrieved
745:
736:
724:. Retrieved
720:
695:. Retrieved
689:
664:. Retrieved
651:
639:. Retrieved
635:
625:
613:. Retrieved
609:the original
604:
595:
583:. Retrieved
578:
569:
557:. Retrieved
553:the original
548:
539:
527:|first=
507:. Retrieved
497:
485:. Retrieved
480:
456:. Retrieved
452:
443:
431:. Retrieved
427:
418:
406:. Retrieved
402:
392:
380:. Retrieved
370:
358:. Retrieved
353:
344:
332:. Retrieved
328:
319:
306:
302:
298:
241:
227:
220:
213:
206:
203:
183:
176:
166:
163:
160:
157:
152:
151:
142:
141:
136:
135:
132:
117:
110:
95:
88:
83:
82:
22:Mark Kendall
15:
1393:1972 births
636:www.ted.com
46:Nationality
1387:Categories
311:References
173:Background
126:, and the
56:Occupation
50:Australian
34:1972-04-16
780:0261-3077
449:"Authors"
1342:cite web
1302:cite web
746:UniQuest
519:cite web
149:(2017).
64:Employer
1371:10 June
1327:UQ News
1287:UQ News
1266:10 June
1241:10 June
1212:10 June
1187:10 June
1162:10 June
1141:10 June
1116:10 June
1095:10 June
1069:10 June
815:10 June
785:10 June
751:10 June
726:10 June
697:10 June
666:10 June
615:10 June
214:At the
207:At the
1332:8 June
1292:9 June
1044:8 June
1019:9 June
993:9 June
967:9 June
942:9 June
917:9 June
892:8 June
866:8 June
840:9 June
778:
641:8 June
585:8 June
559:8 June
509:9 June
487:8 June
458:8 June
433:8 June
408:8 June
382:8 June
360:8 June
334:8 June
397:WEF.
1373:2020
1348:link
1334:2020
1308:link
1294:2020
1268:2020
1243:2020
1214:2016
1189:2020
1164:2020
1143:2020
1118:2020
1097:2020
1089:CBNS
1071:2020
1046:2020
1021:2020
995:2020
969:2020
944:2020
919:2020
894:2020
868:2020
842:2020
817:2020
787:2020
776:ISSN
753:2020
728:2020
699:2016
668:2016
643:2020
617:2020
587:2020
561:2020
531:help
511:2020
489:2020
481:CBNS
460:2020
435:2020
410:2020
384:2020
362:2020
336:2020
236:and
28:Born
886:ANU
860:ANU
354:ANU
264:CSL
1389::
1364:.
1344:}}
1340:{{
1325:.
1304:}}
1300:{{
1285:.
1259:.
1234:.
1222:^
1205:.
1180:.
1134:.
1087:.
1062:.
1037:.
1012:.
985:.
960:.
935:.
910:.
884:.
858:.
833:.
803:.
774:.
770:.
744:.
719:.
707:^
688:.
676:^
659:.
634:.
603:.
577:.
547:.
523::
521:}}
517:{{
479:.
468:^
451:.
426:.
401:.
352:.
327:.
232:,
181:.
93:.
36:)
1375:.
1350:)
1336:.
1310:)
1296:.
1270:.
1245:.
1216:.
1191:.
1166:.
1145:.
1120:.
1099:.
1073:.
1048:.
1023:.
997:.
971:.
946:.
921:.
896:.
870:.
844:.
819:.
789:.
755:.
730:.
701:.
670:.
645:.
619:.
589:.
563:.
533:)
513:.
491:.
462:.
437:.
412:.
386:.
364:.
338:.
153:•
143:•
137:•
32:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.